The role of p27Kip1 phosphorylation at Serine 10 in the migration of malignant glioma cells in vitro

Neoplasma

Volumn 58, Issue 1, 2011, Pages 65-73

  Wang, D ^a   He, F ^a   Zhang, L ^a   Zhang, F ^a   Wang, Q ^a   Qian, X ^a   Pan, X ^a   Meng, J ^a   Peng, C ^a   Shen, A ^b   Chen, J ^b  

^a NANTONG MEDICAL COLLEGE   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

Glioma; Migration

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLINE; LAMININ; PROTEIN P27; SERINE; CDKN1B PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ARTICLE; CELL ACTIVATION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; BRAIN TUMOR; CELL MOTION; DRUG ANTAGONISM; DRUG EFFECT; GLIOMA; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; TUMOR CELL LINE;

BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; GLIOMA; HUMANS; LAMININ; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SERINE;

EID: 79961100034     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2011_01_65     Document Type: Article

References (41)

1. DEMUTH T, RENNERT J, HOELZINGER D, REAVIE L, NAKADA M et al. Glioma cells on the run - the migratory transcriptome of 10 human glioma cell lines. BMC Genomics 2008; 9; 54-69. doi:10.1186/1471-2164-9-54.
2. STUPP R, HEGI M, GILBERT M, CHAKRAVARITY A Chemoradiotherapy in malignant glioma: standard of care and future directions. J Clin Oncol 2007; 25; 4127-4136. doi:10.1200/JCO.2007.11.8554.
3. SOFFIETTI R, LEONCINI B, RUDA R New developments in the treatment of malignant gliomas. Expert Rev Neurother 2007; 7; 1313-1326. doi:10.1586/14737175.7.10.1313.
4. HWANG J, SMITH C, SALHIA B, RUTKA J The role of fascin in the migration and invasiveness of malignant glioma cells. Neoplasia 2008; 10; 149-159. doi:10.1593/neo.07909.
5. DEMUTH T, BERENS M Molecular mechanisms of glioma cell migration and invasion. J Neurooncol 2004; 70; 217-228. doi:10.1007/s11060-004-2751-6.
6. JOY A, BEAUDRY C, TRAN N, PONCE F, HOLZ D et al. Migrating glioma cells activate the PI3-K pathway and display decreased susceptibility to apoptosis. J Cell Sci 2003; 116; 4409-4417. doi:10.1242/jcs.00712.
7. WANG X, LUI E, CAI Q, CHING W, LIU K, et al. p27Kip1 promotes migration of metastatic hepatocellular carcinoma cells. Tumour Biol 2008; 29; 217-223. doi:10.1159/000152939.
8. BALDASSARRE G, BELLETTI B, NICOLOSO M, Schiap-Pacassi M, VECCHOONE A, et al p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion. Cancer Cell 2005; 7; 51-63. doi:10.1016/j.ccr.2004.11.025.
9. Beesson A, Gurian-West M, Schmidt A, Hall A, Roberts J p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 2004; 18; 862-876.
10. Mcallister S, Becker-Hapak M, Pintucci G, Pagano M, DOWDY S Novel p27(kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions. Mol Cell Biol 2003; 23; 216-228. doi:10.1128/MCB.23.1.216-228.2003.
11. Goukassian D, Diez-Juan A, Asahara T, Schratz-Berger P, Silver M et al. Overexpression of p27(Kip1) by doxycycline-regulated adenoviral vectors inhibits endothelial cell proliferation and migration and impairs angiogenesis. FASEB J 2001; 15; 1877-1885. doi:10.1096/fj.01-0065com.
12. J. SUN, S. O. MARX, H. J. CHEN, M. POON, A. R. Marks et al. Role for p27(Kip1) in Vascular Smooth Muscle Cell Migration. Circulation 2001; 103; 2967-2972.
13. Ridley A, Schwartz M, Burridge K, Firtel R, Ginsberg M, et al. Cell migration: integrating signals from front to back. Science 2003; 302; 1704-1709. doi:10.1126/science.1092053.
14. NGUYEN L, BESSON A, HENG J, SCHUURMANS C, TEBOUL L et al. p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex. Genes Dev 2006; 20; 1511-1524. doi:10.1101/gad.377106.
15. DANIEL C, PIPPIN J, SHANKLAND S, HUGO C The rapamycin derivative RAD inhibits mesangial cell migration through the CDK-inhibitor p27KIP1. Lab Invest 2004; 84; 588-596. doi:10.1038/labinvest.3700078.
16. CASSIMERIS L The oncoprotein 18/stathmin family of microtubule destabilizers. Curr Opin Cell Biol 2002; 14; 18-24. doi:10.1016/S0955-0674(01)00289-7.
17. SCHIAPPACASSI M, LOVAT F, CANZONIERI V, BELLETTI B, BERTON S et al. p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis. Mol Cancer Ther 2008; 7; 1164-1175. doi:10.1158/1535-7163.MCT-07-2154.
18. VALSTER A, TRAN N, NAKADA M, BERENS M, CHAN A et al. Cell migration and invasion assays. Methods 2005; 37; 208-215. doi:10.1016/j.ymeth.2005.08.001.
19. LENFERINK A, BUSSE D, FLANAGAN W, YAKES F, ARTEAGA C et al. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways. Cancer Res 2001; 61; 6583-6591.
20. Besson A, Gurian-West M, Chen X, Kelly-Spartt K, Kemp C et al. A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression. Genes Dev 2006; 20; 47-64. doi:10.1101/gad.1384406.
21. ISHIDA N, HARA T, KAMURA T, YOSHIDA M, NAKAYAMA K et al. Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J Biol Chem 2002; 277; 14355-14358. doi:10.1074/jbc.C100762200.
22. WANG Y, CHENG C, JI Y, ZHAO Y, ZOU L et al. Expression of Jun activation domain-binding protein 1 and Ser10 phosphorylated p27 protein in human epithelial ovarian carcinoma. J Cancer Res Clin Oncol 2009; 135; 951-959. doi:10.1007/s00432-008-0531-y.
23. Kelly-Spratt Ks, Philipp-Staheli J, Gurley Ke, Hoon-Kim K, Knoblaugh S, et al. Inhibition of PI-3K restores nuclear p27Kip1 expression in a mouse model of K-ras driven lung cancer. Oncogene 2009; 28; 3652-3662 doi:10.1038/onc.2009.226.
24. GAVERT N, CONACCI-SORRELl M, GAST D, SCHNEIDER A, ALTEVOGT P et al. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol 2005; 168; 633-642. doi:10.1083/jcb.200408051.
25. LOUIS D, POSNER J, JACOBS T, KAPALN R Report of the Brain Tumor Progress Review Group; 2000.
26. GUO W, GIANCOTTI F Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 2004; 5; 816-826. doi:10.1038/nrm1490.
27. BOGENRIEDER T, HERLYN M Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 2003; 22; 6524-6536. doi:10.1038/sj.onc.1206757.
28. HSU M, MEIER F, HERLYN M Melanoma development and progression: a conspiracy between tumor and host. Differentiation 2002; 70; 522-536. doi:10.1046/j.1432-0436.2002.700906.x.
29. LEVIN V, PHUPHANICH S, YUNG W, FORSYTH P, MAESTRO R et al. Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation. J Neurooncol 2006; 78; 295-302. doi:10.1007/s11060-005-9098-5.
30. WEBB D, DONAIS K, WHITMORE L, THOMAS S, TURNER C et al. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 2004; 6; 154-161. doi:10.1038/ncb1094.
31. CARRAGHER N, FRAME M Focal adhesion and actin dynamics: a place where kinases and proteases meet to promote invasion. Trends Cell Biol 2004; 14; 241-249. doi:10.1016/j.tcb.2004.03.011.
32. Nagahara H, Vocero-Akbani A, SNYDER E, HO A, LATHAM D et al. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med 1998; 4; 1449-1452. doi:10.1038/4042.
33. LARREA M, HONG F, WANDER S, SILVA T, HELFMAN D et al. RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility. Proc Natl Acad Sci U S A 2009; 106; 9268-9273. doi:10.1073/pnas.0805057106.
34. KOSSATZ U, VERVOORTS J, NICKELEIT I, SUNDBERG H, ARTHUR J et al. C-terminal phosphorylation controls the stability and function of p27kip1. EMBO J 2006; 25; 5159-5170. doi:10.1038/sj.emboj.7601388.
35. MIN Y, CHEONG J, KIM J, EOM J, LEE S et al. Cytoplasmic mislocalization of p27Kip1 protein is associated with constitutive phosphorylation of Akt or protein kinase B and poor prognosis in acute myelogenous leukemia. Cancer Res 2004; 64; 5225-5231. doi:10.1158/0008-5472.CAN-04-0174.
36. FUKUMOTO A, IKEDA N, SHO M, TOMODA K, KANEHIRO H et al. Prognostic significance of localized p27Kip1 and potential role of Jab1/CSN5 in pancreatic cancer. Oncol Rep 2004; 11; 277-284.
37. ROSEN D, YANG G, CAI K, BAST R, Jr. et al. Subcellular localization of p27kip1 expression predicts poor prognosis in human ovarian cancer. Clin Cancer Res 2005; 11; 632-637.
38. Li R, Wheeler T, Dai H, Sayeeduddin M, Scardino P et al. Biological correlates of p27 compartmental expression in prostate cancer. J Urol 2006; 175; 528-532. doi:10.1016/ S0022-5347(05)00151-5.
39. DENICOURT C, SAENZ C, DATNOW B, X CUI, DOWDY S et al. Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma. Cancer Res 2007; 67; 9238-9243. doi:10.1158/0008-5472.CAN-07-1375.
40. WU F, WANG S, SANDERS M, SHIN I, ROJO F et al. Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, and tumorigenicity. Cancer Res 2006; 66; 2162-2172. doi:10.1158/0008-5472.CAN-05-3304.
41. BESSON A, HWANG H, CICERO S, DONOVAN S, Gurian-West M et al. Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype. Genes Dev 2007; 21; 1731-1746. doi:10.1101/gad.1556607.